Market value of leading molecules in the cardiac segment India FY 2020

Rosuvastatin was the leading molecule drug in cardiac segment in the Indian pharmaceutical market with a market value of almost ten billion Indian rupees in financial year 2020. Sun Pharmaceuticals, Glenmark and Mankind companies had a strong presence in top ten molecules that year.

罗苏伐他汀在2020财年印度医药市场中占据心血管领域主导地位，其市场规模接近一百亿印度卢比。当年，Sun Pharmaceuticals、Glenmark和Mankind等公司均位列前十位主要分子药物之中。